DPC Immulite 2000 GH calibration will be expressed relative to WHO NIBSC 2nd
Int Ref 98/574 shortly. For those of us reporting in mIU/L the results will
decrease by 7%. The bigger question is should we move to reporting in ug/l
as advocated by Wieringa, Barth and Trainer in ClinEndoc last year? What
units do others report in and which analytical platform do they use? If all
reply to me, I'll collate and post a summary. Anne Dawnay UCL Hospitals tel
+44 (0)20 7636 8333 ext 2954
**********************************************************************
This email is confidential and intended solely for the person or entity to whom it is addressed. If this email was not intended for you please notify the UCLH Mail Administrator at [log in to unmask]
This footnote confirms that the email and attachments contained no viruses when they left UCLH.
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|